Skip to content

IMPRA® ePTFE Vascular Grafts 70T74TWCRecalls & reported problems

Bard Peripheral Vascular, Inc. · IMPRA® ePTFE Vascular Graft, Carboflo® Thinwall Tapered Carbon-Lined, 7-4 mm x 70 cm · Class 2 · Implant

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741021664), received between Sep 20, 2021 and Sep 20, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Patient Device Interaction Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Patient Device Interaction Problem1

Patient problems

  • Granuloma1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjurySep 20, 2021Patient Device Interaction Problem; Patient Device Interaction Problem

    IT WAS REPORTED THAT SOME TIME POST GRAFT PLACEMENT, GRANULOMA FORMATION WAS IDENTIFIED. PATIENT UNDERWENT SURGICAL EXCISION TO REMOVE THE GRANULOMA. PATIENT CURRENT STATUS WAS UNKNOWN.

    Patient problems: Granuloma

    MAUDE report 12493816 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF LESS THEN 6MM DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF LESS THEN 6MM DIAMETER devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.